Yvonne Diaz
@Yvonne_Diaz_
Comms professional. Mum to twin sons & a dog. Living w stage 4 ALK+ #lungcancer. Co-founder @OncogeneCancer. Board Member @ALKPositiveInc #ResearchMatters #LCSM
ID:1515061275088150528
https://instagram.com/yvonne_diaz_lc?igshid=OGQ5ZDc2ODk2ZA== 15-04-2022 20:15:47
2,1K Tweets
955 Followers
838 Following
To what extent are those impacted by #lungcancer in Europe involved in shared decision making?
People & caregivers impacted are invited to complete this short, anonymous survey from Lung Cancer Europe.
Takes only 10-15 mins. 👉de.surveymonkey.com/r/LuCESurvey20…
#lcsm #Patient #Advocacy
Amazing #patientadvocates speaking with IASLC about #lungcancer #cancersupport #advocacy . Listen in👇
Yvonne Diaz AnnabelleGurwitch #lcsm
Seeing more and more 5+ year survival for Lung Cancer is the very definition of hope - Yvonne Diaz
D. Ross Camidge
oncodaily.com/blog/65412.html
#Cancer #LCSM #Cancer Survival #OncoDaily #Oncology
Today we pay tribute to the life & legacy of Ilissa, another young mom gone way too soon from lung cancer. Visibility of YLC honors the past, present, & future survivors of change. #neverforget #lcsm #medtwitter #cancerjourney #bohky #anyonewithlungs ylci.org/tribute/ilissa…
The ongoing development of Nuvalent’s zidesamtinib (NVL-520) is an important step forward for our ROS-1 #lungcancer & #cancer community. Here Dr Stephen V Liu, MD highlights the great promise & limited low grade toxicities.
onclive.com/view/dr-liu-on…
#lcsm ROS1ders UK The ROS1ders, Inc.
Lung cancer has many faces! Each person's journey is unique #Cancersurvivorship ALK Positive ALK+ International Yvonne Diaz Narjust Florez, MD, FASCO
Looking forward to helping to host our ALK Positive ALKtALK tonight w/ the amazing Dr Narjust Florez, MD, FASCO and our ALKtALK co-host Summer Farmen.
Living as well as possible is vital to our ALK community. Tune in at 6pm ET/11pm UK.
📺alkpositive.org/alktalk #LCSM #QualityofLife
Thank you to ACS Journal Cancer for highlighting the #FlorezLab's Pregnancy and Lung Cancer Registry by Narjust Florez, MD, FASCO et al. on the front page of the June 1 issue‼️ 👏👏👏👏👏
Read June Issue now⤵️: acsjournals.onlinelibrary.wiley.com/toc/10970142/2…
Fantastic news for our ALK+ #lungcancer community 🙌
The U.S. FDA has granted breakthrough therapy designation to Nuvalent's NVL-655 for the treatment of patients with locally advanced or metastatic ALK+ LC who have been previously treated 2+ TKIs.
#LCSM #ResearchSavesLives
Amongst the enthusiasm for Tarlatamab approval, let’s please pause to remember the pts with SCLC who were the true pioneers. Their time, devotion, + belief in the hope of research made this advance possible 🙏 LiveLung LUNGevity Foundation GO2 for Lung Cancer IASLC #LCSM Jill Feldman
Looking for get involved in #Cancersupport advocacy? We're speaking about lung cancer but convo applicable to all. Join us for this live and lively discussion of advocacy across continents. IASLC ASCO, thnx Yvonne Diaz for hosting.
🚨Stay tuned for the next ALKtALK session by ALK Positive. This conversation will be centered around Empowering Wellness- Navigating body image, family dynamics, sexuality & #QOL with Narjust Florez, MD, FASCO‼️
🗓️: Sunday, May 19th 2024
⌚️: 6pm ET
alkpositive.org/alktalk
In this age of #PrecisionMedicine , shouldn't drugs be funded according to #biomarker vs tumour origin?
Elaine Lynch's #lungcancer is HER2+, associated w #breastcancer . Her family is self-funding Enhertu bc not indicated for lung & can't keep up
👉metro.co.uk/2024/05/13/nev… #lcsm